Worthing rolls out animal-free bioprocessing enzymes

By Gareth Macdonald contact

- Last updated on GMT

Worthing Biochemical launches animal free enzymes
Worthing Biochemical launches animal free enzymes
Worthing Biochemical has launched a range of animal product-free bioprocessing enzymes citing demand for products with no risk of TSE contamination.

The new enzymes – which include collagenases, nucleases and proteases – are certified “xeno-free” - meaning that they contain no non-human animal products. This minimizes the risk of contamination by prion diseases or mammalian viruses according to Worthing.

Company vice president Jim Zacka said: “The use of animal free enzymes eliminates many of the quality and regulatory issues and concerns associated with enzymes commonly purified from animal sources​.”

He added that: “The demand for safer enzymes and biopharmaceuticals has led Worthington to develop an array of Animal Free (AF) enzymes for biomedical research and related bioprocessing applications​.”

Worthing makes its enzymes at its ISO 9001 Certified facility located in the Lakewood, New Jersey, deriving them from fungal and bacterial sources.

Related news

Related product

Accelerating Time to IND with Pharma 4.0

Accelerating Time to IND with Pharma 4.0

Wheeler Bio | 22-Sep-2022 | Technical / White Paper

The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation.

Related suppliers

Follow us

Products

View more

Webinars